Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused with Archaeal DNA-binding Protein Sis7a

Por um escritor misterioso
Last updated 25 março 2025
Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused  with Archaeal DNA-binding Protein Sis7a
Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused  with Archaeal DNA-binding Protein Sis7a
Comparison of the salt tolerance of Sso7d fusions and the unmodified
Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused  with Archaeal DNA-binding Protein Sis7a
Characterization of a fusion NeqSSB-TaqS DNA polymerase in comparison
Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused  with Archaeal DNA-binding Protein Sis7a
Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused with Archaeal DNA-binding Protein Sis7a
Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused  with Archaeal DNA-binding Protein Sis7a
Graphical presentation of the relative adaptiveness (wij) of the codon
Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused  with Archaeal DNA-binding Protein Sis7a
Activity of the M-MuLV RT point mutants. The 50 8 /37 8 C activity
Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused  with Archaeal DNA-binding Protein Sis7a
Distribution of CAI values of the C.elegans genome under different
Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused  with Archaeal DNA-binding Protein Sis7a
HADDOCK web server statistics (as of September 1st 2015). The worldwide
Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused  with Archaeal DNA-binding Protein Sis7a
Expression of Codon-Optimized Gene Encoding Murine Moloney Leukemia Virus Reverse Transcriptase in Escherichia coli
Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused  with Archaeal DNA-binding Protein Sis7a
The NiceProt view of a SWISS-PROT entry presents its contents in a

© 2014-2025 startwindsor.com. All rights reserved.